Zenith Drugs IPO

Zenith Drugs Limited

₹1,20,000 /1600 sharesMinimum Investment

Zenith Drugs IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
19 Feb ‘24 - 22 Feb ‘24₹1,20,0001,600₹75 - ₹79
Issue SizeIPO Doc
40.68Cr
RHP PDF

About Zenith Drugs

Zenith Drugs Limited is a pharmaceutical manufacturing and trading company based in Indore. The company produces medicines, including generics. Some of its products include ORS powder, liquid orals, ointments, liquid externals and capsules. Currently, the company has FDA approval of over 600 products from Food & Drugs Administration. Out of these, it manufactures 325 products regularly. As per the company, it adheres to WHO-GMP guidelines and has received the ISO 9001:2015 certification (Euro-UK Certification body).;
Founded in
2000
Managing director
Mr. Sandeep Bhardwaj
Parent organisation
Zenith Drugs Limited

Strengths & Financials of Zenith Drugs

Strengths
Risks
As per the company, it is able to employ cost efficiency while producing pharmaceuticals. The company also conducts white-label manufacturing for some pharmaceutical companies.
The company has some international presence and distribution networks spanning a few countries. Its products are distributed in countries such as Costa Rica, Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan and Combodia, etc.
The company has a wide product portfolio that includes generic drugs, branded pharmaceuticals, over-the-counter (OTC) products, and specialized medications.
The company has reported positive revenue from operations and profit after tax in the last 3 financial years. Revenue from operations was Rs. 73.40 cr, Rs. 91.65 cr, and Rs. 114.51 cr in FY 2021, 2022 and 2023 respectively. Profit after tax was Rs. 3.03 cr, Rs. 3.13 cr, and Rs. 5.15 cr for these 3 years respectively.

Zenith Drugs Financials

*All values are in Rs. Cr
No Graph Data To Display

Application Details of Zenith Drugs IPO

Apply asPrice bandApply upto
Regular75 - 79₹2 Lakh
High Networth Individual75 - 79₹2 - 5 Lakh
For Zenith Drugs IPO, eligible investors can apply as Regular.
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.6.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW